Abametapir
N/A
Report date: 2022/04/06 10:55:48
NMEFirst In Class
Base Information
Drug NameAbametapir
Drug Alias Name +[10]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2020/07/24
Country/Territory
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesHatchtech Pty Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesPelthos Therapeutics IncHatchtech Pty LtdDr.Reddy's Laboratories Ltd
Active IndicationsN/A
Inactive Indications